Status:
ACTIVE_NOT_RECRUITING
Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy.
Lead Sponsor:
Mansoura University
Conditions:
Unilateral Cleft Lip
Eligibility:
All Genders
10+ years
Phase:
NA
Brief Summary
the aim of the study will be directed to evaluate clinically the effect of botulinum toxin type A injection on reducing the scar following cleft lip surgical repair.
Eligibility Criteria
Inclusion
- inclusion criteria :
- patients with mild to severe unilateral cleft lip requiring repair
- free from any systemic disease
- with or without cleft palate exclusion criteria :
- 1- patients with syndromic type of cleft lip 2- patients with systemic disease
Exclusion
Key Trial Info
Start Date :
March 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2026
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT07137234
Start Date
March 15 2025
End Date
January 1 2026
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University
Al Mansurah, Egypt